Search Results

Site Search

A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights

Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...

Instrucciones para pagos internacionales - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Meet our experts - Insights

Connect with us at the American Academy of Neurology Annual Meeting to learn how our evaluations can inform your clinical practice.

Stories - Eye on Innovation Archives - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

mc1235-69-lead-and-heavy-metals-reporting-spanish.pdf

T956 ©2023 Mayo Foundation for Medical Education and Research MC1235-69SPrev0823 Informes sobre plomo y metales pesados Lead and Heavy Metals Reporting (Spanish) Page 1 of 2 La siguiente información debe ser proporcionada para todas las...

Clinical excellence - Insights

Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.

A simpler path to answers for patients with mast cell activation syndrome - Insights

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by...

Lab in action - Insights

Learn how Mayo Clinic Laboratories and hospitals we work with around the world balance strong financial performance and world-class patient care.

New AI-augmented test refines kidney stone analysis - Insights

Since March 2019, Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, along with his colleagues across the enterprise and his laboratory staff, have developed, validated, and implemented an artificial intelligence...

Testing for a surprising antigen enables insight into a chronic kidney illness - Insights

Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about...

Widening the net to capture elusive pathogens - Insights

Central nervous system infections, such as meningitis and encephalitis, can be devastating for affected patients. While specific treatments are available for some of these infections, it first requires identifying the precise cause of...

Pediatric neuro-oncology informative cases - Insights

Neuro-oncology is a complex field undergoing rapid changes with the advancement and evolution of sophisticated genetic testing. Evidence continues to grow in support of broad molecular and cytogenetic analysis for patients with brain...

October 2023 - Clinical Microbiology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.

How digital pathology provides faster answers - Insights

Almost four years ago, Mayo Clinic launched the Digital Pathology Program, a major pathology initiative. Phase 2 of this multi-phase rollout has recently been completed, which involved the implementation of cutting-edge digital equipment...

Leveraging technology to transform Anatomic Pathology - Insights

As Mayo Clinic’s Anatomic Pathology moves from traditional glass slides to digital images, the advance in technology is achieving clear benefits in collaboration, learning, and patient care.

Revolutionizing Endometrial Cancer Diagnostics - Insights

Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...

Precision in the pancreas: A new genetic test transforms hereditary pancreatitis diagnosis and care - Insights

Mayo Clinic Laboratories’ newly expanded Hereditary Pancreatitis Gene Panel is transforming how clinicians diagnose and manage a complex, often elusive disease. Developed through close collaboration between lab scientists, genetic...

Relentless innovation - Insights

Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.

Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights

Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...

Converging on a major milestone in digital pathology - Insights

Successful implementation of a new slide scanning and analysis platform across five laboratories represents a significant step forward in Mayo Clinic’s digital pathology program — an initiative that combines advanced technology with human...

MCL Autoimmune Axonal Neuropathy A Comprehensive Testing Approach MC2775425

MCL Autoimmune Axonal Neuropathy Comprehensive Testing Approach NEUROLOGY AUTOIMMUNE AXONAL NEUROPATHY COMPREHENSIVE TESTING APPROACH Patients neuropathy variable sensory motor disturbance loss exaggerated

Mayo Clinic Laboratory and pathology research roundup: July 25 - Insights

This week's research roundup feature: The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.

Mayo Clinic Laboratory and pathology research roundup: September 5 - Insights

This week's research roundup feature: 16S rRNA gene PCR/Sequencing of heart valves for diagnosis of infective endocarditis in routine clinical practice.

Mayo Clinic Laboratory and pathology research roundup: August 22 - Insights

This week's research roundup feature: Association of plasma biomarkers of Alzheimer Disease with cognition and medical comorbidities in a biracial cohort.

Mayo Clinic Laboratory and pathology research roundup: August 15 - Insights

This week's research roundup feature: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.

MCL Genetics Whole Genome Sequencing Flyer MC2775658

MCL Genetics Genome Sequencing Flyer GENOME SEQUENCING COMPREHENSIVE GENETIC TESTING ADVANCE DIAGNOSIS Clinic Laboratories genome sequencing WGS test utilizes generation

Mayo Clinic Laboratory and pathology research roundup: July 4 - Insights

This week's research roundup feature: Emergence of inducible macrolide resistance in mycobacterium chelonae due to broad-host-range plasmid and chromosomal variants of the novel 23S rRNA methylase gene, erm(55).

Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights

This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.

Mayo Clinic Laboratory and pathology research roundup: July 11 - Insights

This week's research roundup feature: Comparison of two assays to diagnose herpes simplex virus in patients with central nervous system infections.

The Living Breast Biobank - Insights

This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.

New high-resolution urine drug testing profile - Insights

Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol,...

An inside look at the state-of-the-art supports enabling invention - Insights

A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that...

How an ex-NFL Linebacker Overcame His Greatest Opponent, Amyloidosis - Insights

Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.

Neurology - Insights

A collaboration with Mayo Clinic BioPharma Diagnostics includes access to the neurologic disease testing capabilities of Mayo Clinic Laboratories. Our highly specialized neurology testing menu features more than 400 neurologist-backed...

Mayo Clinic Laboratory and pathology research roundup: June 27 - Insights

This week's research roundup feature: SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.

Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights

This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.

Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights

This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

Whole exome sequencing - Insights

Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.

Whole genome sequencing - Insights

Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.

Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights

In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases.

Pleural Mesothelioma - Insights

In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.

Alzheimer's Disease CSF Biomarkers - Insights

In this month's "Hot Topic," Alicia Algeciras, Ph.D., DABCC, and Joshua Bornhorst, Ph.D., DABCC, discuss Alzheimer's disease CSF biomarkers.

Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights

This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.

Mayo Clinic Laboratory and pathology research roundup: August 8 - Insights

This week's research roundup feature: Age-based versus young-adult thresholds for nephrosclerosis on kidney biopsy and prognostic implications for CKD.

Bile acid malabsorption - Insights

Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...

Pathways Case Studies: June 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Dermatopathology, Gastroenterology...

MCL Whole Exome Sequencing Advanced Understanding of Genetic Disease Flyer MC2775523

MCL Exome Sequencing Advanced Understanding Genetic Disease Flyer EXOME SEQUENCING ADVANCED UNDERSTANDING GENETIC DISEASE millions individuals affected rare diseases 80

July 2023 - Cytopathology and Pulmonary Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cytopathology & Pulmonary Pathology.

CNS Demyelinating Disease Testing - Mayo Clinic Laboratories

We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.

Eye on Innovation - Insights

Eye on Innovation features exciting advances taking place at Mayo Clinic Laboratories. This monthly series shines a spotlight on recently developed tests, and highlights how Mayo Clinic translates ideas and discoveries into testing...